Nicolas Chatain

16PUBLICATIONS
30CO-AUTHORS
Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cheminformatics and quantitative structure-activity relationshipsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 24, 2026
Selective dependency of CALR-mutant myeloproliferative neoplasms on TYK2 signaling.

|Dec 23, 2023
Exploiting Synthetic Lethality between Germline BRCA1 Haploinsufficiency and PARP Inhibition in JAK2V617F-Positive Myeloproliferative Neoplasms.

Max Bermes, Maria Jimena Rodriguez, Marcelo Augusto Szymanski de Toledo

|Mar 29, 2023
KIT D816V Mast Cells Derived from Induced Pluripotent Stem Cells Recapitulate Systemic Mastocytosis Transcriptional Profile.

Marcelo A S de Toledo, Xuhuang Fu, Tiago Maié

|Dec 22, 2022
Evaluation of Chiral Organosulfur Compounds on Their Activity against the Malaria Parasite Plasmodium falciparum.

Che Julius Ngwa, Rabea Stratmann, Jean Pierre Musabyimana

|Oct 21, 2022
Clonogenic assays improve determination of variant allele frequency of driver mutations in myeloproliferative neoplasms.

Milena Kalmer, Kristina Pannen, Rebecca Lemanzyk

|Dec 24, 2021
Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives.

Julian Baumeister, Nicolas Chatain, Alexandros Marios Sofias

Pageof 3

Frequent Collaborators

13 joint publications

Steffen Koschmieder

5 joint publications

Ivan G Costa

5 joint publications

Tim Henrik Brümmendorf

2 joint publications

Marcelo Augusto Szymanski de Toledo